HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Osteoporosis Foundation Discusses Evidence To Increase Vitamin D RDA

This article was originally published in The Tan Sheet

Executive Summary

The National Osteoporosis Foundation joins other research groups calling for an increase to the recommended daily allowance of vitamin D

You may also be interested in...



Pediatricians Double Recommended Vitamin D Intake, Suggest Earlier Use

The American Academy of Pediatrics doubles its recommendation for daily vitamin D intake by infants, children and adolescents to 400 IU and advises earlier supplementation with the vitamin

Adding Supplements to Federal Support Programs Needs Industry Push – NPA

A proposal to exclude vitamin D supplementation from a federal nutrition program and continued apathy in Congress toward adding multivitamins and dietary supplements to the food stamp program are signals it is time for the industry to push harder for change, a Natural Products Association executive says

Vitamin D Review Shows No Consensus On Optimum Levels For Bone Health

A review of vitamin D studies reflects uncertainty among researchers concerning how much of the vitamin is needed for optimal bone health and about differences in the relationship between vitamin D and bone health across age groups and life stages, the National Institutes of Health's Office of Dietary Supplements says

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS138496

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel